Diarrhea Associated with Mesalamine in a Patient with Chronic Nongranulomatous Enterocolitis
Authors:
- Kenneth D. FineKFKenneth D. Fine
- Harry E. SarlesHSHarry E. Sarles
- Byron CryerBCByron Cryer
- 26 March 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (13) , 923-925
Abstract
The use of mesalamine (5-aminosalicylic acid) for the treatment of inflammatory bowel disease seems paradoxical, since structurally similar acetylsalicylic acid and other nonsteroidal antiinflammatory drugs (NSAIDs) can cause or exacerbate intestinal inflammation and diarrhea through their effects on arachidonic acid metabolism.1 We describe a patient with inflammatory bowel disease of the small bowel and colon who had large-volume diarrhea while fasting during treatment with mesalamine, which was associated with changes in fecal eicosanoid content that mimicked effects expected with the use of NSAIDs that relieve pain.Keywords
This publication has 5 references indexed in Scilit:
- Nongranulomatous chronic idiopathic enterocolitis: Clinicopathologic profile and response to corticosteroidsGastroenterology, 1996
- Exacerbation of chronic ulcerative colitis with mesalamineGastroenterology, 1995
- Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitroGastroenterology, 1988
- Nonsteroidal Anti-Inflammatory Drugs Activate Quiescent Inflammatory Bowel DiseaseAnnals of Internal Medicine, 1987
- EXACERBATION OF DIARRHOEA AND PAIN IN PATIENTS TREATED WITH 5-AMINOSALICYLIC ACID FOR ULCERATIVE COLITISThe Lancet, 1984